#702 — The Industry Wire

April 30, 2025 Brian Casey 0 min read
  1. FDA misses review deadline for genetic drug candidate.
  2. Supreme Court sides with HHS on hospital payments.
  3. Tenet to continue M&A for ambulatory surgery centers. 
  4. C-suite compensation grew 20% in 2024. 
  5. FDA ruling ends era of compounded GLP-1 weight-loss drugs.
  6. Humana to shore up Medicare Advantage business. 
  7. Penn. bill would legalize OTC ivermectin sales. 
  8. GOP senator calls for reversal of federal research cuts.
  9. FDA debates whether to approve seasonal COVID shots.
  10. RFK Jr.: Don’t flush unused medications. 
Get every issue of The Imaging Wire, delivered right to your inbox.

You might also like

CT Scanners July 30, 2026

CT Radiation Dose Drops in Nationwide Survey July 30, 2026

Radiation dose delivered to patients from CT scans has fallen markedly over the past decade in the U.S.

Digital breast tomosynthesis (A) vs. 2D digital mammography (B)

Breast Imaging July 27, 2026

AI Closes Mammo Gap Between Generalists, Specialists July 27, 2026

An AI-based workflow for mammography screening helped close the cancer detection gap between specialists and general radiologists.

Oncology Imaging July 24, 2026

Gaps in Global Cancer Burden Widen July 24, 2026

About 20.6M people worldwide were diagnosed with cancer in 2024, a nearly 7% increase from 2020, according to an update from WHO.